Serum Insulin-like Growth Factor (IGF)-I and IGF-binding proteins in lung cancer patients

Journal of Korean Medical Science

Volumn 14, Issue 4, 1999, Pages 401-404

  Lee, Dae Yeol ^a   Kim, Sun Jun ^a   Lee, Yong Chul ^a  

^a Chonbuk National University Medical School   (South Korea)

Author keywords

Insulin like growth factor binding proteins; Insulin like growth factor I; Lung neoplasms; Serum

Indexed keywords

SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN 2; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; TUMOR MARKER;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; BLOOD; FEMALE; HUMAN; LUNG TUMOR; MALE; METABOLISM; MIDDLE AGED; RADIOIMMUNOASSAY; SMALL CELL CARCINOMA; SQUAMOUS CELL CARCINOMA; WESTERN BLOTTING;

ADENOCARCINOMA; ADULT; AGED; BLOTTING, WESTERN; CARCINOMA, SMALL CELL; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 2; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; INSULIN-LIKE GROWTH FACTOR II; LUNG NEOPLASMS; MALE; MIDDLE AGED; RADIOIMMUNOASSAY; TUMOR MARKERS, BIOLOGICAL;

EID: 0033174947     PISSN: 10118934     EISSN: None     Source Type: Journal    
DOI: 10.3346/jkms.1999.14.4.401     Document Type: Article

References (20)

1. El-Badry OM, Romanus JA, Helman LJ, Cooper MJ, Rechler MM, Israel MA. Autonomous growth of a human neuroblastoma cell line is mediated by insulin-like growth factor II. J Clin Invest 1989; 84: 829-39.
2. Holly JMP, Wass JAH. Insulin-like growth factors; autocrine, paracrine or endocrine? New perspectives of the somatomedin hypothesis in the light of recent developments. J Endocrinol 1989; 122: 611-8.
3. Baxter RC, Martin JL. Structure of the Mr 140,000 growth hormone-dependent insulin-like growth factor binding protein complex: determination by reconstitution and affinity-labelling. Proc Natl Acad Sci U.S.A. 1989; 86: 6898-902.
4. Reeve AE, Eccles MR, Wilkins RJ, Bell GI, Millow LJ. Expression of insulin-like growth factor II transcripts in Wilms tumor. Nature 1985; 317: 258-60.
5. De Leon DD, Wilson DM, Bakker B, Lamson G, Hintz RL, Rosenfeld RG. Characterization of insulin-like growth factor (IGF) binding proteins from human breast cancer cells. Mol Endocrinol 1989; 3: 567-74.
6. Reeve JG, Payne JA, Bleehen NM. Production of immunoreactive insulin-like growth factor-I (IGF-I) and IGF-I binding proteins by human lung tumours. Br J Cancer 1990; 61: 727-31.
7. Bhatavdekar JM, Patel DD, Chikhlikar PR, Mehta RH, Vora HH, Karelia NH, Ghosh N, Shah NG, Suthar TP, Neema JP, Balar DB. Levels of circulating peptide and steroid hormones in men with lung cancer. Neoplasma 1994; 41: 101-3.
8. Reeve JG, Morgan J, Clark PMS, Bleehen NM. Insulin-like growth factor (IGF) and IGF binding proteins in growth hormone dysregulation and abnormal glucose tolerance in small cell lung cancer patients. European J cancer 1995; 31A: 1455-60.
9. Hossenlopp P, Seurin D, Segovia-Quinson B, Hardouin S, Binoux M. Analysis of serum insulin-like growth factor binding proteins using western blotting: use of the method for titration of the binding proteins and competitive binding studies. Anal Biochem 1986; 154: 138-43.
10. Gazdar AF, Carney DN, Minna JD. The biology of non-small cell lung cancer. Semin Oncol 1983; 10: 3-19.
11. Zapf J, Froesch ER. Pathophysiological and clinical aspects of insulin-like groHth factors. Hormone Res 1986; 24: 160-5.
12. Tisi E, Lissoni P, Mandelli D, Barni S, Tancini G. Blood levels of IGF-I in non-small cell lung cancer: relation to clinical data. Int J Biological Markers 1991; 6: 99-102.
13. Clemmons DR, Snyder DK, Busby WH Jr. Variables controlling the secretion of insulin-like growth factor binding protein-2 in normal human subjects. J Clin Endocrinol Metab 1991; 73: 727-33.
14. Blum WF, Horn N, Kratzsch J, Jorgensen JOL, Juul A, Teale D, Mohnike K, Ranke MB. Clinical studies of IGFBP-2 by radioimmunoassay. Growth Regulation 1993; 3: 100-4.
15. Jacques G, Kiefer P Schoneberger HJ, Wegmann B, Kaiser U, Brandscheid D, Havemann K. Differential expression of insulin-like growth factor binding proteins in human non-small cell lung cancer cell lines. Eur J Cancer 1992; 28A: 1899-904.
16. Cohen P, Peehl DM, Stamey TH, Wilson K, Clemmons DR, Rosenfeld RG. Elevated levels of insulin-like growth factor-binding protein-2 in the serum of prostate cancer patients. J Clin Endocrinol Metab 1993; 76: 1031-5.
17. Rechler MM, Nissley SP. Insulin-tike growth factors. In: Sporn MB, Roberts AB, eds. Peptide growth factors and their receptors 1. Berlin: Springer-Verlag, 1990: 263-76.
18. Lee D-Y, Cohen P, Krensky AM, Rosenfeld RG, Yorgin PD. Insulin-like growth factor binding protein-3 protease activity in the urine of children with chronic renal failure. Pediatr Nephrol 1993; 7: 416-23.
19. Hossenlopp P, Segovia B, Lassarre C, Roghani M, Bredon M, Binoux M. Evidence of enzymatic degradation of insulin-like growth factor-binding porteins in the 150 K complex during pregnancy. J Clin Endocrinol Metab 1990; 71: 797-805.
20. Kanety H, Madjar Y, Dagan Y, Levi J, Papa MZ, Pariente C, Goldwasser B, Karasik A. Serum insulin-like growth factor-binding protein-2 (IGFBP-2) is increased and IGFBP-3 is decreased in patients with prostate cancer: correlation with serum prostate-specific antigen. J Clin Endocrinol Metab 1993; 77: 229-33.